Page last updated: 2024-08-26

indobufen and Cerebrovascular Disorders

indobufen has been researched along with Cerebrovascular Disorders in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (50.00)	18.7374
1990's	4 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrieri, P; D'Acunio, F; Iadevaia, V; Indaco, A; La Pia, S; Orefice, G	1
Buscaino, GA; De Michele, G; Majello, L; Mansi, D; Palma, V	1
Coccheri, S; Morocutti, C	1
Amabile, G; Fattapposta, F; Heiman, F; Lavezzari, M; Matteoli, S; Morocutti, C; Trappolini, M	1
Buckley, MM; Fitton, A; Wiseman, LR	1
Belcaro, G; Cesarone, MR; De Cenzo, A; Errichi, BM; Laurora, G; Marinucci, R	1

Reviews

1 review(s) available for indobufen and Cerebrovascular Disorders

Article	Year
Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease. Drugs, 1992, Volume: 44, Issue:3 Topics: Cerebrovascular Disorders; Coronary Disease; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Vascular Diseases	1992

Trials

6 trial(s) available for indobufen and Cerebrovascular Disorders

Article	Year
Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach. Pharmatherapeutica, 1983, Volume: 3, Issue:6 Topics: Adult; Aged; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation	1983
Long-term trial (6 months) of the platelet aggregation inhibitory activity and biological safety of indobufen in cerebrovascular patients. Acta neurologica, 1983, Volume: 5, Issue:6 Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Time Factors	1983
[Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)]. Il Giornale di chirurgia, 1995, Volume: 16, Issue:3 Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Embolism; Female; Follow-Up Studies; Humans; Isoindoles; Italy; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Warfarin	1995
Aspirin and prevention of stroke. Lancet (London, England), 1994, Jan-22, Volume: 343, Issue:8891 Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Warfarin	1994
[Italian Study on Atrial Fibrillation (SIFA): status report]. Cardiologia (Rome, Italy), 1993, Volume: 38, Issue:12 Suppl 1 Topics: Adult; Aged; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Isoindoles; Italy; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Warfarin	1993
Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group. International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:8 Topics: Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Isoindoles; Male; Middle Aged; Patient Compliance; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Time Factors	1985

Other Studies

1 other study(ies) available for indobufen and Cerebrovascular Disorders

Article	Year
[Chronic treatment of vascular diseases with indobufen]. Minerva cardioangiologica, 1989, Volume: 37, Issue:5 Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Vascular Diseases; Veins	1989